HLA-B52
| B*5101-β2MG with bound peptide 1e27 | ||
major histocompatibility complex (human), class I, B52
| ||
| Alleles | B*5201, 5202, 5203, . . . | |
| Structure (See HLA-B) | ||
| Shared data | ||
| Locus | chr.6 6p21.31 | |
HLA-B52 (B52) is an HLA-B serotype. The serotype identifies the more common HLA-B*52 gene products.[1]
B52 is a split antigen of the broad antigen B5, and is a sister type of B51. B*5201 likely formed as a result of a gene conversion event between another HLA-B allele and HLA-B*5101.[2] There are a number of alleles within the B*52 allele group.[3]
Serotype
| B*52 | B52 | B5 | B51 | B53 | Sample |
| allele | % | % | % | % | size (N) |
| *5201 | 84 | 2 | 7 | 1 | 2823 |
| Alleles link-out to IMGT/HLA Databease at EBI | |||||
| freq | ||
| ref. | Population | (%) |
| [5] | China Yunnan Lisu | 21.7 |
| [5] | China Yunnan Nu | 18.6 |
| [5] | Bulgaria Gipsy | 18.2 |
| [5] | Venezuela Sierra de Perija Yucpa | 12.8 |
| [5] | India Andhra Pradesh Golla | 12.0 |
| [5] | Japan Central | 10.7 |
| [5] | Japan | 10.4 |
| [5] | Georgia Tbilisi Kurds | 10.3 |
| [5] | Mali Bandiagara | 8.3 |
| [5] | South Africa Natal Tamil | 8.2 |
| [5] | Israel Ashk. and Non-Ashk. Jews | 7.3 |
| [5] | India North Hindus | 6.7 |
| [5] | China Beijing | 6.1 |
| [5] | India New Delhi | 6.1 |
| [5] | India Mumbai Marathas | 5.6 |
| [5] | Tunisia Ghannouch | 5.5 |
| [5] | Thailand pop3 | 5.1 |
| [5] | India West Coast Parsis | 5.0 |
| [5] | India North Delhi | 4.9 |
| [5] | Mexico Mestizos | 4.9 |
| [5] | Argentina Toba Rosario | 4.7 |
| [5] | Mexico Zaptotec Oaxaca | 4.5 |
| [5] | USA Hispanic | 4.5 |
| [5] | China Qinghai Hui | 4.1 |
| [5] | China Inner Mongolia | 3.9 |
| [5] | China North Han | 3.8 |
| [5] | Oman | 3.8 |
| [5] | Senegal Niokholo Mandenka | 3.7 |
| [5] | Bulgaria | 3.6 |
| [5] | Thailand | 3.5 |
| [5] | Ivory Coast Akan Adiopodoume | 3.4 |
| [5] | Venezuela Perja Mountain Bari | 3.4 |
| [5] | Italy North pop 1 | 3.3 |
| [5] | Sudanese | 3.3 |
| [5] | Romanian | 3.2 |
| [5] | Singapore Riau Malay | 3.0 |
| [5] | Autonomous Region Tibetans | 2.8 |
| [5] | Russia Tuva pop 2 | 2.8 |
| [5] | South Korea pop 3 | 2.8 |
| [5] | Iran Baloch | 2.5 |
| [5] | Tunisia | 2.5 |
| [5] | Jordan Amman | 2.4 |
| [5] | USA Hawaii Okinawa | 2.4 |
| [5] | Singapore Javanese Indonesians | 2.0 |
| [5] | Spain Eastern Andalusia | 1.8 |
| [5] | Macedonia pop 4 | 1.6 |
| [5] | Uganda Kampala | 1.6 |
| [5] | Belgium | 1.5 |
| [5] | Mexico Guadalajara Mestizos pop2 | 1.5 |
| [5] | Singapore Thai | 1.5 |
| [5] | Brazil | 1.4 |
| [5] | China Yunnan Lisu | 1.4 |
| [5] | Azores Santa Maria and Sao Miguel | 1.3 |
| [5] | France South East | 1.2 |
| [5] | Italy North Pavia | 1.2 |
| [5] | Saudi Arabia Guraiat and Hail | 1.2 |
| [5] | Mexico Chihuahua State Tarahumara | 1.1 |
| [5] | Tunisia Tunis | 1.1 |
| [5] | Israel Arab Druse | 1.0 |
| [5] | Japan Ainu Hokkaido | 1.0 |
| [5] | Portugal Centre | 1.0 |
| [5] | Singapore Chinese | 1.0 |
| [5] | Taiwan Minnan pop 1 | 1.0 |
| [5] | USA Caucasian | 1.0 |
| [5] | Azores Central Islands | 0.9 |
| [5] | China South Han | 0.9 |
| [5] | Macedonia pop 4 | 0.7 |
| [5] | Morocco Nador Metalsa Class I | 0.7 |
| [5] | Georgia Svaneti Svans | 0.6 |
| [5] | Ireland South | 0.6 |
| [5] | Italy Bergamo | 0.6 |
Alleles
There are 18 alleles, with 14 amino acid sequence variants in B52. Of these only 9 are frequent enough to have been reliably serotyped. B*5201 is the most common, but others have a large regional abundance.
Disease
In ulcerative colitis
HLA-B52 appears to have the strongest linkage to ulcerative colitis in Japan.[6][7] This form of disease is frequently found with Takayasu's arteritis.[8][9]
In Takayasu's arteritis
Takayasu's arteritis appears to have an independent link to B52 associated disease.[10][11] The association with B*5201 increases risk of pulmonary infarction, ischemic heart disease, aortic regurgitation, systemic hypertension, renal artery stenosis, cerebrovascular disease, and visual disturbance.[12]
References
- ^ Marsh, S. G.; Albert, E. D.; Bodmer, W. F.; Bontrop, R. E.; Dupont, B.; Erlich, H. A.; Fernández-Viña, M.; Geraghty, D. E.; Holdsworth, R.; Hurley, C. K.; Lau, M.; Lee, K. W.; Mach, B.; Maiers, M.; Mayr, W. R.; Müller, C. R.; Parham, P.; Petersdorf, E. W.; Sasazuki, T.; Strominger, J. L.; Svejgaard, A.; Terasaki, P. I.; Tiercy, J. M.; Trowsdale, J. (2010). "Nomenclature for factors of the HLA system, 2010". Tissue Antigens. 75 (4): 291–455. doi:10.1111/j.1399-0039.2010.01466.x. PMC 2848993. PMID 20356336.
- ^ Cox ST, McWhinnie AJ, Robinson J, et al. (January 2003). "Cloning and sequencing full-length HLA-B and -C genes" (PDF). Tissue Antigens. 61 (1): 20–48. doi:10.1034/j.1399-0039.2003.610103.x. PMID 12622774. Archived from the original (PDF) on 2008-10-28. Retrieved 2008-08-03.
- ^ Hayashi H, Ennis PD, Ariga H, et al. (January 1989). "HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domain". J. Immunol. 142 (1): 306–11. PMID 2909619.
- ^ derived from IMGT/HLA
- ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf bg bh bi bj bk bl bm bn bo bp bq br bs Middleton D, Menchaca L, Rood H, Komerofsky R (2003). "New allele frequency database". Tissue Antigens. 61 (5): 403–7. doi:10.1034/j.1399-0039.2003.00062.x. PMID 12753660.
- ^ Sugimura K, Asakura H, Mizuki N, et al. (February 1993). "Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis". Hum. Immunol. 36 (2): 112–8. doi:10.1016/0198-8859(93)90113-F. PMID 8096500.
- ^ Nomura E, Kinouchi Y, Negoro K, et al. (September 2004). "Mapping of a disease susceptibility locus in chromosome 6p in Japanese patients with ulcerative colitis". Genes Immun. 5 (6): 477–83. doi:10.1038/sj.gene.6364114. PMID 15215890.
- ^ Oyanagi, Hironobu; Ishihata, R; Ishikawa, H; et al. (February 1994), "Ulcerative colitis associated with Takayasu's disease", Intern. Med., 33 (2): 127–129, doi:10.2169/internalmedicine.33.127, PMID 7912572
- ^ Sato, R; Sato, Y; Ishikawa, H; et al. (December 1994), "Takayasu's disease associated with ulcerative colitis", Intern. Med., 33 (12): 759–763, doi:10.2169/internalmedicine.33.759, PMID 7718956
- ^ Kimura A, Kitamura H, Date Y, Numano F (August 1996). "Comprehensive analysis of HLA genes in Takayasu arteritis in Japan". Int. J. Cardiol. 54 Suppl: S61–9. doi:10.1016/s0167-5273(96)88774-2. PMID 9119528.
- ^ Yoshida M, Kimura A, Katsuragi K, Numano F, Sasazuki T (August 1993). "DNA typing of HLA-B gene in Takayasu's arteritis". Tissue Antigens. 42 (2): 87–90. doi:10.1111/j.1399-0039.1993.tb02242.x. PMID 7903491.
- ^ Kitamura H, Kobayashi Y, Kimura A, Numano F (October 1998). "Association of clinical manifestations with HLA-B alleles in Takayasu arteritis". Int. J. Cardiol. 66 Suppl 1: S121–6. doi:10.1016/S0167-5273(98)00159-4. PMID 9951811.
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.